Poly(ADP-ribosylation) as target for cancer chemotherapy
- 11 September 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 342 (8872) , 632
- https://doi.org/10.1016/0140-6736(93)91756-c
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- NEW DIRECTIONS FOR THE ANTI-RETROVIRAL CHEMOTHERAPY OF AIDS - A BASIS FOR A PHARMACOLOGICAL APPROACH TO TREATMENTBiological Reviews, 1993
- Role of poly(ADP-ribose) formation in DNA repairNature, 1992
- NEW TARGETS FOR CANCER CHEMOTHERAPY – POLY(ADPRIBOSYLATION) PROCESSING AND POLYISOPRENE METABOLISMBiological Reviews, 1990
- Prevention of tumorigenesis of oncogene-transformed rat fibroblasts with DNA site inhibitors of poly(ADP ribose) polymerase.Proceedings of the National Academy of Sciences, 1987
- ADP-RIBOSYLATIONAnnual Review of Biochemistry, 1985
- Novel inhibitors of poly(ADP-ribose) synthetaseBiochemical Journal, 1980